RELAPSED/REFRACTORY SMALL CELL LUNG CANCER
Clinical trials for RELAPSED/REFRACTORY SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new RELAPSED/REFRACTORY SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for RELAPSED/REFRACTORY SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hard-to-treat lung cancer: experimental combo enters human trials
Disease control Recruiting nowThis study tests an experimental drug called BMS-986525, given alone or with another drug (nivolumab), in people whose small cell lung cancer has returned or stopped responding to standard treatments. The main goals are to check safety and find the right dose. About 240 adults wi…
Matched conditions: RELAPSED/REFRACTORY SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 10, 2026 14:54 UTC
-
Experimental CAR t therapy targets tough lung cancer in first human trial
Disease control Recruiting nowThis early study tests a new treatment called GC511B for people with a type of lung cancer (small cell) that has come back or stopped responding to standard care. The treatment uses the patient's own immune cells, modified in a lab to better recognize and attack cancer cells. The…
Matched conditions: RELAPSED/REFRACTORY SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 08, 2026 12:03 UTC